All over the world there is an increasing demand from citizens and patients to legalise medical cannabis for the treatment of selected diseases – including multiple sclerosis, spinal cord injury and chronic pain.
Many countries and authorities have therefore chosen to pave the way for various forms of legalisation of cannabis for medical purposes.
CiBiD Group has built a medical cannabis eco-system including GMP production facilities. This exclusive eco-system makes it possible to offer a high-quality intermediate product to pharmacies which both patients and authorities can have confidence in.